MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB

被引：0
|
作者：
Rice, Ceara [1 ]
Ghandi-Das, Dhivya [1 ]
Negi, Anurag [1 ]
机构：
[1] Univ Hosp Wales, Rheumatol, Cardiff, Wales
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P202
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Rebound of multiple sclerosis in patients treated with anti CD20 after discontinuation of rituximab
    Missione, Rosanna
    Signoriello, Elisabetta
    Bonavita, Simona
    Lus, Giacomo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [2] Changes in Immunoglobulin in Patients with Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies
    Vollmer, Brandi
    Bourassa, Timber
    Dao, Vi
    Sillau, Stefan
    Alvarez, Enrique
    Nair, Kavita
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 340 - 340
  • [3] Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases
    Reis, J.
    Aguiar, F.
    Brito, I
    ACTA REUMATOLOGICA PORTUGUESA, 2016, 41 (01): : 45 - 55
  • [4] Influence of CD20 depletion (Rituximab) on gene expression levels in patients with rheumatoid arthritis.
    Kekow, J
    Koczan, D
    Drynda, S
    Thiesen, HJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4062 - 4062
  • [5] Rituximab in CD20 positive multiple myeloma
    J M Bergua
    C Cabrera
    E G Arteta
    J Prieto
    Leukemia, 2008, 22 : 1082 - 1083
  • [6] Intratissutal effects of anti CD20 rituximab (RTX) in a patient with Graves' ophtalmopathy
    Bonara, P.
    Frugoni, C.
    Vannucchi, G.
    Campi, I.
    Rossi, S.
    Sbrozzi, C.
    Salvi, M.
    Beck-Peccoz, P.
    CYTOMETRY PART A, 2008, 73A (01) : 88 - 89
  • [7] Rituximab in CD20 positive multiple myeloma
    P Moreau
    L Voillat
    L Benboukher
    C Mathiot
    C Dumontet
    N Robillard
    O Hérault
    F Garnache
    R Garand
    N Varoqueaux
    H Avet-Loiseau
    J L Harousseau
    R Bataille
    Leukemia, 2007, 21 : 835 - 836
  • [8] Transient downmodulation of CD20 by rituximab.
    Jilani, I
    O'Brien, S
    Manshouri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    BLOOD, 2002, 100 (11) : 804A - 804A
  • [9] Rituximab in CD20 positive multiple myeloma
    Moreau, P.
    Voillat, L.
    Benboukher, L.
    Mathiot, C.
    Dumontet, C.
    Robillard, N.
    Herault, O.
    Garnache, F.
    Garand, R.
    Varoqueaux, N.
    Avet-Loiseau, H.
    Harousseau, J. L.
    Bataille, R.
    LEUKEMIA, 2007, 21 (04) : 835 - +
  • [10] Rituximab in CD20 positive multiple myeloma
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1082 - 1083
12345